PRAX: Praxis Precision Medicines, Inc.
Performance
PRAX +97.94%
Watchlist
Select an item
Summary
PRAX at a glance
PRAX returned +97.94% over the past year and +0.06% a year over five years. Its worst drop in that year was -38.13%, smaller than 40% of stocks on Redstone, and its Sharpe ratio of 1.23 beats 84% of stocks on Redstone. It pays no dividends.
Current Drawdown
-13.81%
Rolling Volatility
90.33%
Actions
Metrics
Risk Indicators
Alpha76.96%
Beta1.57x
Sharpe1.23
Sortino2.12
Omega1.26
Calmar2.57
Martin6.25
Profile
About PRAX
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $9.3B
- Listed
- Oct 2020
- Employees
- 10,998
- Headquarters
- Boston, MA
- Website
- praxismedicines.com
Comparisons